Skip to main content
    C

    Charles River Laboratories (CRL)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $332.11
    -3.41 (-1.02%)

    Market Cap: $16.08B

    Last updated: Nov 17, 2026 at 4:20 PM ET

    Charles River Laboratories (CRL) Stock Chart

    Updated Nov 17, 2026. Prices from end-of-day market data; valuation figures from company filings.

    Charles River Laboratories (CRL) has a latest price of $332.11 on Nov 17, 2026, 12.5% below its 52-week high of $379.63. Its price rose 97.9% over the past 12 months. The month-end price rose 373.7% over the 10 years through Oct 2026, a compound annual rate of 16.8%.

    Price Chart

    From Oct 2016 to Oct 2026, its highest month-end close was $448.68 in Oct 2021 and its lowest $71.10 in Nov 2016, adjusted for splits.

    Month-end closes, adjusted for splits. Dividends are not included.

    Chart CRL with Advanced Charting

    Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for CRL.

    Free with a GNG account. No credit card.

    Price Performance

    Over the past 3 months the price rose 14.5%, and over 6 months it rose 117.9%. The month-end price rose 113.5% over the 3 years through Oct 2026, a compound annual rate of 28.8%.

    PeriodChange
    1 month+10.7%
    3 months+14.5%
    6 months+117.9%
    12 months+97.9%
    12 months, with dividends+97.9%
    Price change over each period. Dividends are not included unless the row says so.
    PeriodChangePer year
    3 years+113.5%+28.8%
    5 years-19.9%-4.3%
    10 years+373.7%+16.8%
    From month-end closes through Oct 2026. Per year is the compound annual rate.

    Price by Year

    Its best calendar year was 2020, when the price rose 63.6%, and its weakest was 2022, when it fell 42.2%.

    YearCloseChange
    2026 through Oct 2026$359.41+80.2%
    2025$199.48+8.1%
    2024$184.60-21.9%
    2023$236.40+8.5%
    2022$217.90-42.2%
    2021$376.78+50.8%
    2020$249.86+63.6%
    2019$152.76+35.0%
    2018$113.18+3.4%
    2017$109.45+43.7%
    Each year ends at its December month-end close, adjusted for splits.

    Trading Range

    The price is 6.1% above its 50-day average of $313.03 and 45.1% above its 200-day average of $228.93.

    MeasureValuePrice vs
    Latest price (Nov 17, 2026)$332.11
    52-week high$379.63-12.5%
    52-week low$146.20+127.2%
    50-day average$313.03+6.1%
    200-day average$228.93+45.1%
    Moving averages of daily closes. The last column compares the price with each level.

    Price Risk

    Over 3 years, its largest fall from a peak was 63.5%.

    MeasureValue
    1-year beta1.26
    Largest fall, 1 year-33.9%
    Largest fall, 3 years-63.5%
    Beta against the S&P 500 over one year. A fall is measured from a peak to the low after it.

    Valuation

    Charles River Laboratories traded at 19.4x earnings at the end of 2025, against a 5-year median of 19.4x and a 10-year median of 20.5x.

    CRL valuation history

    Advanced Charting Features

    Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.

    • Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
    • Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
    • Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
    • Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.

    Frequently Asked Questions About CRL

    What is CRL's 1-year price change?

    Charles River Laboratories's price rose 97.9% over the past 12 months. With dividends included, the 12-month total return was 97.9%.

    What is CRL's 5-year price change?

    Charles River Laboratories's month-end price fell 19.9% over the 5 years through Oct 2026, a compound annual decline of 4.3%. These figures leave out dividends.

    What is CRL's 52-week high and low?

    Charles River Laboratories's 52-week high is $379.63 and its 52-week low is $146.20. Its latest price of $332.11 on Nov 17, 2026 is 12.5% below the high.

    What is CRL's beta?

    Charles River Laboratories's 1-year beta against the S&P 500 is 1.26, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 33.9%.

    Is the CRL chart free?

    Yes. Advanced Charting for CRL is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.